Patents Represented by Attorney James H. Monroe
-
Patent number: 4654466Abstract: This invention relates to an inbred line of corn having the designation 78010, seeds produced by plants of the inbred line 78010, cells which upon growth and differentiation produces the inbred line 78010, hybrid corn seed produced by crossing the inbred line 78010 with another corn line and a process for the production of hybrid corn seed using the inbred line 78010.Type: GrantFiled: April 29, 1985Date of Patent: March 31, 1987Assignee: Dekalb-Pfizer GeneticsInventor: Marvin F. Lindsey
-
Patent number: 4629794Abstract: A series of novel antibacterially active derivatives of indolmycin as well as some prodrug forms of indolmycin is disclosed. A novel process for the production of these compounds is also disclosed.Type: GrantFiled: January 23, 1986Date of Patent: December 16, 1986Assignee: Pfizer Inc.Inventor: John P. Dirlam
-
Patent number: 4626610Abstract: A soybean variety which is a high yielder and resistant to iron deficiency chlorosis.Type: GrantFiled: January 11, 1985Date of Patent: December 2, 1986Assignee: DeKalb-Pfizer GeneticsInventor: Paul Sun
-
Patent number: 4607453Abstract: Novel F1 hybrid corn plants DK 672, novel seeds of the hybrid, seeds produced by cultivation of the hybrid, cells which upon growth and differentiation produce the novel hybrid and a method to produce the novel hybrid are disclosed.Type: GrantFiled: February 21, 1985Date of Patent: August 26, 1986Assignee: DeKalb-Pfizer GeneticsInventor: A. Forrest Troyer
-
Patent number: 4602067Abstract: An aqueous drilling fluid suitable for high-temperature use comprising a water base, clay suspended in said base and from about 0.01-25 pounds per barrel total composition of a hydrolyzed terpolymer of maleic anhydride, styrene and a third monomer selected from acrylamide, methacrylamide, acrylic acid or methacrylic acid, the molar ratio of maleic anhydride to styrene to said third monomer being from about 30:10:60 to 50:40:10, and the alkali metal, ammonium and lower aliphatic amine salts thereof, the weight-average molecular weight of said hydrolyzed terpolymer being from about 500-10,000. An improved drilling process wherein such fluids remain flowable at elevated temperatures is also disclosed.Type: GrantFiled: March 28, 1985Date of Patent: July 22, 1986Assignee: Pfizer Inc.Inventors: Randel E. Stong, Stanley W. Walinsky
-
Patent number: 4584009Abstract: Herbicidal compositions containing salinomycin for the control of weeds are disclosed.Type: GrantFiled: December 13, 1984Date of Patent: April 22, 1986Assignee: Pfizer Inc.Inventors: Meiro Adachi, Kenji Hamada
-
Patent number: 4584385Abstract: A series of novel antibacterially active derivatives of indolmycin as well as some prodrug forms of indolmycin is disclosed. A novel process for the production of these compounds is also disclosed.Type: GrantFiled: February 4, 1985Date of Patent: April 22, 1986Assignee: Pfizer Inc.Inventor: John P. Dirlam
-
Patent number: 4578354Abstract: A process for immobilizing enzyme-containing microbial cells by contacting such cells with an aqueous agar solution containing from about 1.0 to 8.0% sulfate moiety on a weight/weight basis, contacting a solution of inorganic sodium salts with a stream of the cell mixture whereby agar fibers containing cells are formed; and recovering the cell-containing agar fibers produced.Type: GrantFiled: May 9, 1983Date of Patent: March 25, 1986Assignee: Pfizer Inc.Inventor: John J. Cannon
-
Patent number: 4566978Abstract: An aqueous drilling fluid suitable for high-temperature use comprising a water base, clay suspended in said base and from about 0.01-25 pounds per barrel total composition of a hydrolyzed terpolymer of maleic anhydride, styrene and a third monomer selected from acrylamide, methacrylamide, acrylic acid or methacrylic acid, the molar ratio of maleic anhydride to styrene to said third monomer being from about 30:10:60 to 50:40:10, and the alkali metal, ammonium and lower aliphatic amine salts thereof, the weight-average molecular weight of said hydrolyzed terpolymer being from about 500-10,000. An improved drilling process wherein such fluids remain flowable at elevated temperatures is also disclosed.Type: GrantFiled: May 21, 1984Date of Patent: January 28, 1986Assignee: Pfizer Inc.Inventors: Randel E. Stong, Stanley W. Walinsky
-
Patent number: 4562197Abstract: L-pyroglutamyl-pyridylalanyl-L-prolinamides of the formula: ##STR1## wherein R.sup.1 is H, C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.7 cycloalkyl, C.sub.2 -C.sub.8 alkoxyalkyl or aryl; and X is H, halo, C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy; and their physiologically acceptable salts and feed compositions thereof are useful for improving the efficiency of feed utilization and/or growth of animals especially poultry.Type: GrantFiled: November 13, 1984Date of Patent: December 31, 1985Assignee: Pfizer Inc.Inventors: Michael Snarey, Peter J. Swift, Michael J. Witty
-
Patent number: 4495284Abstract: A process for the preparation of 1-carvone (spearmint flavor) comprises cultivating a carvone producing microorganism of the genus Pseudomonas in an aqueous nutrient media in the presence of 1-.alpha.- or 1-.beta.-pinene.Type: GrantFiled: November 22, 1982Date of Patent: January 22, 1985Assignee: Pfizer Inc.Inventors: Peter M. Rhodes, Norman Winskill
-
Patent number: 4466889Abstract: A stable xanthan solution with superior filterability and subterranean injectivity characteristics comprising biopolymer and a chelating agent selected from aliphatic alpha-hydroxy acids having from about 2-7 carbon atoms; aliphatic and aromatic beta-keto compounds having from about 4-9 carbon atoms; or 2- and 4-pyrones having a hydroxyl group alpha to the carbonyl and having 5 or 6 carbon atoms; said chelating agent being present in an amount of at least about 1.0 ppm of the total solution. A method of enhancing oil recovery comprising employing as a mobility control solution in oil-bearing formations a mixture of xanthan biopolymer and a chelating agent is also disclosed.Type: GrantFiled: August 20, 1981Date of Patent: August 21, 1984Assignee: Pfizer Inc.Inventors: James W. Miller, Bryce E. Tate
-
Patent number: 4363912Abstract: A series of novel 3-(pyrid-3- or -4-ylalkyl)-indoles useful as inhibitors of the action of the thromboxane synthetase enzyme without significantly inhibiting the action of the prostacyclin synthetase or cyclo- oxygenase enzymes is disclosed.Type: GrantFiled: December 3, 1981Date of Patent: December 14, 1982Assignee: Pfizer Inc.Inventors: Peter E. Cross, Roger P. Dickinson
-
Patent number: 4351845Abstract: Oral administration of lasalocid to swine in the grower and finisher phases of their life cycle results in an increase in the rate of growth and in the efficiency of feed utilization.Type: GrantFiled: March 12, 1981Date of Patent: September 28, 1982Assignee: Pfizer Inc.Inventor: Jesse E. Shively
-
Patent number: 4336265Abstract: Oral administration of salinomycin and 4-methyl-salinomycin to swine in the grower and finisher phases of their life cycle results in an increase in the efficiency of feed utilization.Type: GrantFiled: November 6, 1980Date of Patent: June 22, 1982Assignee: Pfizer Inc.Inventor: Jesse E. Shively
-
Patent number: 4276183Abstract: Magnetic material comprising magnetic iron oxide modified with at least about 0.5 weight % cobalt, based on the weight of total product which when combined with a binder at a 75% by weight loading forms a magnetic recording member having an orientation ratio and coercivity value that corresponds to a coordinate value equal to or above the coordinate values on the FIGURE and an M-factor value between about -1.0 and +1.0. The magnetic material is preferred in which the amount of cobalt present is from about 0.5 to about 5.0 weight % based on the weight of total product and in which chromium is also present in an amount of from about 0.1 to about 0.3 weight percent based on the weight of total product. A magnetic impulse record member having such a magnetic material dispersed in a binding medium is also claimed.Type: GrantFiled: July 2, 1979Date of Patent: June 30, 1981Assignee: Pfizer Inc.Inventor: David M. Wilson